GlaxoSmithKline
GSK
#208
Rank
$98.04 B
Marketcap
$48.57
Share price
-0.82%
Change (1 day)
45.99%
Change (1 year)

GlaxoSmithKline (GSK) - Total debt

Total debt on the balance sheet as of September 2025 : $23.86 Billion USD

According to GlaxoSmithKline's latest financial reports the company's total debt is $23.86 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

GlaxoSmithKline - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$21.31 B-7.14%
2023-12-31$22.95 B-9.59%
2022-12-31$25.39 B-22.19%
2021-12-31$32.62 B-11.83%
2020-12-31$37.00 B-7.49%
2019-12-31$40.00 B20.92%
2018-12-31$33.08 B43.25%
2017-12-31$23.09 B-0.38%
2016-12-31$23.18 B-5.93%
2015-12-31$24.64 B-15.72%
2014-12-31$29.24 B-2.83%
2013-12-31$30.09 B1.74%
2012-12-31$29.58 B27.72%
2011-12-31$23.16 B-0.64%
2010-12-31$23.31 B-11.39%
2009-12-31$26.30 B10.89%
2008-12-31$23.72 B12.85%
2007-12-31$21.02 B95.56%
2006-12-31$10.74 B-15.36%
2005-12-31$12.69 B10.99%
2004-12-31$11.44 B25.52%
2003-12-31$9.11 B22.45%
2002-12-31$7.44 B21.05%
2001-12-31$6.14 B2.19%
2000-12-31$6.01 B6.11%
1999-12-31$5.67 B9.29%
1998-12-31$5.18 B4.54%
1997-12-31$4.96 B-10.66%
1996-12-31$5.55 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
$32.63 B 36.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
$60.84 B 155.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$41.37 B 73.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$32.02 B 34.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
$25.53 B 7.00%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
$17.07 B-28.45%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
$0.28 B-98.81%๐Ÿ‡บ๐Ÿ‡ธ USA